Transplantation, Autologous

• 

  Subject Areas on Research

  • "Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma. 
  • 14C-labeled acetate incorporation into lipids by vascular tissues. 
  • 4-hydroperoxycyclophosphamide--purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leukemia. 
  • A Biomechanical Evaluation of Auricular Cartilage Autografts in Orbital Floor Defect Repair. 
  • A National Snapshot of Patient-Reported Outcomes Comparing Types of Abdominal Flaps for Breast Reconstruction. 
  • A One-Step Autotransplantation Can Facilitate the Excision of Cardiac Tumors Invading the Lung. 
  • A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen. 
  • A biomechanical study of human lateral ankle ligaments and autogenous reconstructive grafts. 
  • A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer. 
  • A functional tethered ligand thrombin receptor is present on human hematopoietic progenitor cells. 
  • A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma. 
  • A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts. 
  • A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. 
  • A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study. 
  • A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation. 
  • A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254. 
  • A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplant. 
  • A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy. 
  • A radiologic syndrome after high dose chemotherapy and autologous bone marrow transplantation, with clinical and pathologic features of systemic candidiasis. 
  • A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy. 
  • A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation. 
  • A randomized trial of recombinant human interleukin-11 following autologous bone marrow transplantation with peripheral blood progenitor cell support in patients with breast cancer. 
  • A rib-containing free flap to reconstruct mandibular defects. 
  • ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design. 
  • ANZCCSG BabyBrain99; intensified systemic chemotherapy, second look surgery and involved field radiation in young children with central nervous system malignancy. 
  • Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States. 
  • Aerosol transfer of bladder urothelial and smooth muscle cells onto demucosalized colonic segments for bladder augmentation: in vivo, long term, and functional pilot study. 
  • Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. 
  • Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience. 
  • Allograft anterior cruciate ligament reconstruction in a sheep model. The effect of synthetic augmentation. 
  • Alterations in L-selectin expression and elastase activity in neutrophils from patients receiving granulocyte colony-stimulating factor alone or in conjunction with high-dose chemotherapy with autologous bone marrow transplantation. 
  • Alveolar rhabdomyosarcoma that metastasized to the orbit. 
  • Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene. 
  • Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support. 
  • An adherence tensiometer for evaluation of burn dressings. 
  • An allogenic cell-based implant for meniscal lesions. 
  • An expanded series of distal bypass using the distal vein patch technique to improve prosthetic graft performance in critical limb ischemia. 
  • Analysis of failures after vascularized fibular grafting in femoral head necrosis. 
  • Application of stem cell transplantation in autoimmune diseases. 
  • Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial. 
  • Aspirin and dipyridamole decrease intimal hyperplasia in experimental vein grafts. 
  • Assessing the Relationship between Anxiety and Revision Surgery following Autologous Breast Reconstruction. 
  • Auto-SCT for AML in second remission: CALGB study 9620. 
  • Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study. 
  • Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials. 
  • Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation. 
  • Autologous Retinal Transplant for Refractory Macular Holes: Multicenter International Collaborative Study Group. 
  • Autologous Stem-Cell Transplantation for Severe Scleroderma. 
  • Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis. 
  • Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial. 
  • Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research. 
  • Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia. 
  • Autologous bone marrow transplantation for acute lymphoblastic leukemia. 
  • Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination. 
  • Autologous cortical bone grafts with microsurgical anastomosis of periosteal vessels. 
  • Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. 
  • Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease. 
  • Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission. 
  • Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality. 
  • Autologous stem cell transplantation for autoimmune diseases: issues in protocol development. 
  • Autologous stem cell transplantation for pediatric rheumatic diseases. 
  • Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome. 
  • Autologous transplantation followed closely by reduced-intensity allogeneic transplantation as consolidative immunotherapy in advanced lymphoma patients: a feasibility study. 
  • Autologous tumor rejection in humans: trimming the myths. 
  • Avascular necrosis of the talus: current treatment options. 
  • Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors. 
  • Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation. 
  • Bone marrow metastases. 
  • Bone marrow transplantation for hematologic malignancies: the Stanford experience. 
  • Bone marrow transplantation. Part II--autologous. 
  • Bone-grafting in total hip replacement for acetabular protrusion. 
  • Brachial artery reconstruction using the heparin-bonded Sundt shunt. 
  • Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia. 
  • COMBINED AUTOLOGOUS TRANSPLANTATION OF NEUROSENSORY RETINA, RETINAL PIGMENT EPITHELIUM, AND CHOROID FREE GRAFTS. 
  • Can We Cure Light Chain Deposition Disease of the Kidneys?-A Review and Case Report of a Patient Treated With a Triple Transplant Approach. 
  • Can underpowered clinical trials be justified? 
  • Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility? 
  • Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer. 
  • Change in Anterior Cruciate Ligament Graft Choice and Outcomes Over Time. 
  • Characterizing differences between MSCs and TM cells: Toward autologous stem cell therapies for the glaucomatous trabecular meshwork. 
  • Check the Record: Remote CT Scans for Breast Flap Perforator Mapping. 
  • Chronic myopathy due to immunoglobulin light chain amyloidosis. 
  • Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass. 
  • Colony-stimulating factors: clinical applications. 
  • Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. 
  • Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. 
  • Comparison of free flaps with pedicled flaps for coverage of defects of the leg or foot. 
  • Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells. 
  • Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group. 
  • Complete and incomplete revascularization at aortocoronary bypass surgery: experience with 392 consecutive patients. 
  • Complex abdominal wall hernias: a new classification system and approach to management based on review of 133 consecutive patients. 
  • Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas. 
  • Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. 
  • Delayed autotransplantation of a solitary kidney facilitated by pump perfusion preservation. 
  • Delivery of primary autologous skeletal myoblasts into rabbit heart by coronary infusion: a potential approach to myocardial repair. 
  • Delta 9-tetrahydrocannabinol suppression of prolactin secretion in the rat: lack of direct pituitary effect. 
  • Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial. 
  • Disseminated intravascular coagulation and renal failure: Production in the monkey with autologous red blood cell stroma. 
  • Dose intensive melphalan and cyclophosphamide with autologous hematopoietic stem cells for recurrent medulloblastoma or germinoma. 
  • Dynamic assessment of quality of life after autologous bone marrow transplantation. 
  • Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation. 
  • Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma. 
  • Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time. 
  • Early-stage melanoma and hematopoietic stem cell transplantation outcomes. 
  • Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial. 
  • Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial. 
  • Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. 
  • Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. 
  • Efficacy and safety of hematopoietic stem cell remobilization with plerixafor+G-CSF in adult patients with germ cell tumors. 
  • Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma. 
  • Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease. 
  • Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes. 
  • Efficacy of a Cellular Bone Allograft for Foot and Ankle Arthrodesis and Revision Nonunion Procedures. 
  • Electrophysiological Biomarkers Predict Clinical Improvement in an Open-Label Trial Assessing Efficacy of Autologous Umbilical Cord Blood for Treatment of Autism. 
  • Endothelial graft failure after contralateral autologous corneal transplantation. 
  • Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantation. 
  • Enrichment of peripheral blood stem cells in a primate model following administration of a single dose of rh-IL-1 beta. 
  • Epstein-Barr virus-associated lymphoproliferative disorder following autologous bone marrow transplantation for non-Hodgkin's lymphoma. 
  • Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases. 
  • Ethical issues in umbilical cord blood banking. Working Group on Ethical Issues in Umbilical Cord Blood Banking. 
  • Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study. 
  • Evaluation of the spectra Optia® mononuclear cell collection procedure in multiple myeloma patients. 
  • Evidence that biopsying, fragmentation and auto-transplantation of ovarian tissue should be abandoned as a treatment of diminished ovarian reserve. 
  • Ex vivo graft purging and expansion of autologous blood progenitor cell products from patients with multiple myeloma. 
  • Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer. 
  • Exercise echocardiographic comparison of pulmonary autograft and aortic homograft replacements for aortic valve disease in adults. 
  • Experimental cryopreservation and autotransplantation of parathyroid glands: technique and demonstration of function. 
  • Factors associated with infection following anterior cruciate ligament reconstruction. 
  • Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis. 
  • Family-directed umbilical cord blood banking. 
  • Fatal noncutaneous visceral infection with varicella-zoster virus in a patient with lymphoma after autologous bone marrow transplantation. 
  • Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy. 
  • Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation. 
  • Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies. 
  • Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: no improvement in outcomes compared with single-course high-dose therapy. 
  • Fourteen free groin flap transfers. 
  • Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma. 
  • Free vascularized fibular graft reconstruction of large skeletal defects after tumor resection. 
  • Free vascularized fibular grafting preserves athletic activity level in patients with osteonecrosis. 
  • Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. 
  • Functional abnormalities of experimental autogenous vein graft neoendothelium. 
  • Future strategies for the treatment of advanced epithelial ovarian cancer using high-dose chemotherapy and autologous bone marrow support. 
  • Gait abnormalities and inflammatory cytokines in an autologous nucleus pulposus model of radiculopathy. 
  • Generation of autologous tumor-specific cytotoxic T-cells using HLA-A region matched allogeneic melanoma. 
  • Graft-versus-host disease: allo- and autoimmunity after bone marrow transplantation. 
  • Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma. 
  • Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma. 
  • Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF. 
  • High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma. 
  • High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer. 
  • High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. 
  • High-dose chemotherapy and hematopoietic support for patients with high-risk primary breast cancer and involvement of 4 to 9 lymph nodes. 
  • High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes. 
  • High-dose chemotherapy with AHPCS for the treatment of breast cancer. The University of Colorado results. 
  • High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4-9 involved axillary lymph nodes. 
  • High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas. 
  • High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. 
  • High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. 
  • High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support. A clinical and pharmacologic study. 
  • High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy. 
  • High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma. 
  • High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan. 
  • High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. 
  • High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. 
  • High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies. 
  • High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study. 
  • High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial. 
  • High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices. 
  • High-dose therapy with autologous bone marrow transplantation for the treatment of solid tumors. 
  • Histological and biochemical studies of vascular autografts. 
  • Hypertension and reversible myocardial depression associated with autologous bone marrow transplantation. 
  • Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support. 
  • Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation. 
  • Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA. 
  • Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation. 
  • Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma. 
  • Improved quality of life following total pancreatectomy and auto-islet transplantation for chronic pancreatitis. 
  • Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: an analysis from ACT34-CMI. 
  • Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone. 
  • Increased yield of endothelial cells from peripheral blood for cell therapies and tissue engineering. 
  • Induced corneal astigmatism after macular translocation surgery with scleral infolding. 
  • Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma. 
  • Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome in breast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation. 
  • Inhibition of vessel allograft rejection by endothelial removal. Morphologic and ultrastructural changes. 
  • Intimal thickening and hyperlipidemia in experimental primate vascular autografts. 
  • Intracardiac transplantation of skeletal myoblasts yields two populations of striated cells in situ. 
  • Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. 
  • Intramyocardial, autologous CD34+ cell therapy for refractory angina. 
  • Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies. 
  • Is autologous stem cell transplantation still relevant for multiple myeloma? 
  • Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. 
  • LDH isoenzymes and myocardial infarction in patients undergoing coronary bypass surgery: an excellent correlation. 
  • Laceration of the flexor pollicis longus tendon: delayed repair by advancement, free graft or direct suture. A clinical and experimental study. 
  • Laparoscopic intracorporeal harvest of jejunal tissue for autologous transplantation. 
  • Late complications of allogeneic and autologous marrow transplantation. 
  • Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis. 
  • Local Burn Injury Promotes Defects in the Epidermal Lipid and Antimicrobial Peptide Barriers in Human Autograft Skin and Burn Margin: Implications for Burn Wound Healing and Graft Survival. 
  • Long-Segment Fusion for Adult Spinal Deformity Correction Using Low-Dose Recombinant Human Bone Morphogenetic Protein-2: A Retrospective Review of Fusion Rates. 
  • Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. 
  • Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy. 
  • Magnetic Resonance Imaging Characterization and Clinical Outcomes After NeoCart Surgical Therapy as a Primary Reparative Treatment for Knee Cartilage Injuries. 
  • Management of bone in digital replantation: free vascularized and composite bone grafts. 
  • Management of recurrent melanoma of the extremity. 
  • Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases. 
  • Marrow transplantation for malignant plasma cell disorders: summary of the Seattle experience. 
  • Marrow transplantation for patients with acute lymphoblastic leukemia in first marrow remission. 
  • Meralgia paresthetica secondary to trauma of bone graft. 
  • Metacarpal reconstruction with free autogenous cartilage and bone following tumor resection. A case report. 
  • Microsurgical composite tissue transplantation. 
  • Microsurgical composite tissue transplantation: a method of immediate reconstruction of the head and neck. 
  • Microsurgical composite tissue transplantation: a new horizon in plastic and reconstructive surgery. 
  • Microsurgical composite tissue transplantation: a new method of immediate reconstruction of extensive defects. 
  • Microvascular management of ring avulsion injuries. 
  • Microvascular procedures in reconstructive surgery. 
  • Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics. 
  • Modified simple limbal epithelial transplantation using cryopreserved amniotic membrane for unilateral limbal stem cell deficiency. 
  • Monkey median nerve repaired by nerve graft or collagen nerve guide tube. 
  • Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures. 
  • Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma. 
  • Neuromuscular and biomechanical landing performance subsequent to ipsilateral semitendinosus and gracilis autograft anterior cruciate ligament reconstruction. 
  • Neutrophil migration is defective during recombinant human granulocyte-macrophage colony-stimulating factor infusion after autologous bone marrow transplantation in humans. 
  • Noninvasive assessment of the effects of aorta-coronary bypass grafting on ventricular function during rest and exercise. 
  • Older patients with myeloma derive similar benefit from autologous transplantation. 
  • Optimal timing of autologous cranioplasty after decompressive craniectomy in children. 
  • Organ transplantation in HIV-infected patients. 
  • Osseointegrated implants for auricular prostheses: An alternative to autologous repair. 
  • Osteochondral Allograft: Proceedings of the International Consensus Meeting on Cartilage Repair of the Ankle. 
  • Osteochondral autologous transfer system. 
  • Osteochondral lesions: medial versus lateral, persistent pain, cartilage restoration options and indications. 
  • Outcome after autogenous brachial-basilic upper arm transpositions in the post-National Kidney Foundation Dialysis Outcomes Quality Initiative era. 
  • Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone. 
  • Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation. 
  • Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma. 
  • Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma. 
  • Outcomes of selective tibial artery repair following combat-related extremity injury. 
  • Parathyroid autotransplantation: use of cryopreserved glands in an investigation of hypocalcemia. 
  • Pattern formation on lepidopteran wings: determination of an eyespot. 
  • Pediatric femoral avascular necrosis after pyarthrosis: use of free vascularized fibular grafting. 
  • Peripheral blood stem cells for autografting. 
  • Peripheral nerve regeneration: an opinion on channels, scaffolds and anisotropy. 
  • Persistence and survival of autologous muscle derived cells versus bovine collagen as potential treatment of stress urinary incontinence. 
  • Phase I study of subconjunctival ranibizumab in patients with primary pterygium undergoing pterygium surgery. 
  • Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. 
  • Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma. 
  • Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease. 
  • Physiologic Preoperative Knee Hyperextension Is a Predictor of Failure in an Anterior Cruciate Ligament Revision Cohort: A Report From the MARS Group. 
  • Planning and response to radiation exposures. 
  • Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report. 
  • Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma. 
  • Polyclonal long-term MFGS-gp91phox marking in rhesus macaques after nonmyeloablative transplantation with transduced autologous peripheral blood progenitor cells. 
  • Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis. 
  • Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with greater than or equal to 10 positive axillary lymph nodes. Cancer and Leukemia Group B. 
  • Postoperative function of "free" jejunal transplants for replacement of the cervical esophagus. 
  • Preoperative assessment of left ventricular function in patients selected for direct myocardial revascularization. 
  • Preparation techniques for the injection of human autologous cartilage: an ex vivo feasibility study. 
  • Primate skin allotransplantation with anti-CD154 monotherapy. 
  • Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support. 
  • Pubovaginal sling using cadaveric allograft fascia for the treatment of intrinsic sphincter deficiency. 
  • Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support. 
  • Purging of autologous bone marrow for transplantation: the protection and selection of the hematopoietic progenitor cell. 
  • Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066. 
  • Quantitative measures of physical functioning after autologous hematopoietic stem cell transplantation in multiple myeloma: a feasibility study. 
  • Randomized trial of high-dose chemotherapy with autologous bone marrow support as adjuvant therapy for high-risk, multi-node-positive malignant melanoma. 
  • Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy. 
  • Reconstruction of the rabbit trachea with vascularized auricular perichondrium. 
  • Recurrent hyperparathyroidism and forearm parathyromatosis after total parathyroidectomy. 
  • Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002). 
  • Relationship between provider volume and outcomes for orthotopic liver transplantation. 
  • Renal artery aneurysm in a solitary kidney: successful surgical repair. 
  • Renal autotransplants in sheep: investigation of renal function and renovascular hypertension. 
  • Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer. 
  • Repeated autologous umbilical cord blood infusions are feasible and had no acute safety issues in young babies with congenital hydrocephalus. 
  • Reply: The Impact of Autologous Breast Reconstruction on Body Mass Index Patterns in Breast Cancer Patients: A Propensity-Matched Analysis. 
  • Results with titanium ossicular reconstruction prostheses. 
  • Rethinking the ross procedure in adults. 
  • Reticulated platelet counts in patients undergoing autologous bone marrow transplantation: an aid in assessing marrow recovery. 
  • Retinopathy and optic neuropathy after transplantation. 
  • Retinopathy and optic neuropathy in bone marrow transplantation for breast cancer. 
  • Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma. 
  • Risk Factors and Predictors of Significant Chondral Surface Change From Primary to Revision Anterior Cruciate Ligament Reconstruction: A MOON and MARS Cohort Study. 
  • Risk factors in coronary artery bypass surgery. 
  • Risk of distal embolization and infarction with transluminal extraction atherectomy in saphenous vein grafts and native coronary arteries. NACI Investigators. New Approaches to Coronary Interventions. 
  • Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. 
  • Role of Fresh Osteochondral Allografts for Large Talar Osteochondral Lesions. 
  • Role of autotransplantation in treatment of other solid tumors. 
  • Role of cytokines in autologous bone marrow transplantation. 
  • SUCCESSFUL REPAIR OF RECURRENT OPTIC DISK PIT MACULOPATHY WITH AUTOLOGOUS PLATELET RICH PLASMA: REPORT OF A SURGICAL TECHNIQUE. 
  • Salvage of advanced squamous cell carcinomas of the head and neck: internal carotid artery sacrifice and extracranial-intracranial revascularization. 
  • Scaffold-Based Therapies: Proceedings of the International Consensus Meeting on Cartilage Repair of the Ankle. 
  • Secondary failure of platelet recovery after hematopoietic stem cell transplantation. 
  • Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant. 
  • Selection of patients for heterotopic implantation of the areola and nipple. 
  • Selection of patients with Hodgkin's disease and non-Hodgkin's lymphoma for bone marrow transplantation. 
  • Semiautologous repair for congenital discontinuous right pulmonary artery. 
  • Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival. 
  • Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma. 
  • Serum erythropoietin levels and blood component therapy after autologous bone marrow transplantation: implications for erythropoietin therapy in this setting. 
  • Single Steinmann pin fixation of arm to leg. Case report. 
  • Spermine dialdehyde, a novel ex vivo purging agent for both allogenic and autologous bone marrow transplantations. 
  • Spinal bone density following spinal fusion. 
  • Stem cell isolation. 
  • Stem cell transplantation for multiple myeloma. 
  • Stem-cell transplantation for the treatment of advanced solid tumors. 
  • Structural and biochemical alterations in canine arterial autografts. 
  • Structural and biochemical alterations in canine venous autografts. 
  • Subtalar distraction arthrodesis using interpositional frozen structural allograft. 
  • Subtotal vs. total parathyroidectomy with autotransplantation for patients with renal hyperparathyroidism have similar outcomes. 
  • Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. 
  • Surgical management of large talar osteochondral defects using autologous chondrocyte implantation. 
  • Systolic contraction within aneurysmal rabbit myocardium following transplantation of autologous skeletal myoblasts. 
  • T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. 
  • Technology evaluation: Stem-cell therapy, Aastrom Biosciences Inc. 
  • The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction. 
  • The Impact of Autologous Breast Reconstruction on Body Mass Index Patterns in Breast Cancer Patients: A Propensity-Matched Analysis. 
  • The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina. 
  • The Ross procedure: shorter hospital stay, decreased morbidity, and cost effective. 
  • The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: preliminary data. 
  • The effect of cyclooxygenase-2 inhibition on acute and chronic donor-site pain after spinal-fusion surgery. 
  • The histological effect of barrier vein wrapping of peripheral nerves. 
  • The morbidity associated with osteochondral harvest from asymptomatic knees for the treatment of osteochondral lesions of the talus. 
  • The place of microsurgery in hand surgery. 
  • The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation. 
  • The use of autologous adult, allogenic juvenile, and combined juvenile-adult cartilage fragments for the repair of chondral defects. 
  • The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation. 
  • The vascularization of free flaps: a clinical and experimental correlation. 
  • Tibial nerve grafting for restoration of plantar sensation. 
  • Tissue-engineered scaffolds are effective alternatives to autografts for bridging peripheral nerve gaps. 
  • Tissue-engineered vascular grafts: autologous off-the-shelf vascular access? 
  • Topical Review: MACI as an Emerging Technology for the Treatment of Talar Osteochondral Lesions. 
  • Total pancreatectomy and autologous islet cell transplantation as a means to treat severe chronic pancreatitis. 
  • Toxicity, pharmacology and feasibility of administration of PEG-L-asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukemia. 
  • Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. 
  • Transfer of free flaps to provide well-vascularized, thick cover for breast reconstructions after radical mastectomy. 
  • Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research. 
  • Transplantation in miniature swine. 
  • Transplantation of feline islets of Langerhans in the subretinal space of cat eyes. 
  • Transplantation of the parathyroid glands in man: clinical indications and results. 
  • Treatment Outcomes and Health Care Resource Utilization in Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide-only Maintenance, Any Maintenance, or No Maintenance: Results from the Connect MM Registry. 
  • Treatment of Osteonecrosis of the Talus. 
  • Treatment of osteonecrosis of the femoral head with free vascularized fibular grafting. A long-term follow-up study of one hundred and three hips. 
  • Ulnar artery insufficiency: a guide to treatment. 
  • Ultrasound assessment of left ventricular function following aortocoronary saphenous vein bypass grafting. 
  • Umbilical cord blood: a novel alternative source of hematopoietic stem cells for bone marrow transplantation. 
  • Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial. 
  • Urologic surgery. 
  • Value of surgical resection in children with high-risk neuroblastoma. 
  • Variance in Anterior Cruciate Ligament Reconstruction Graft Selection based on Patient Demographics and Location within the Multicenter Orthopaedic Outcomes Network Cohort. 
  • Vascularization and the gliding mechanism of free flexor-tendon grafts inserted by the silicone-rod method. 
  • Vascularized fibula-based physis transfer for pediatric proximal humerus reconstruction. 
  • Vascularized rib-periosteal and osteocutaneous reconstruction of the maxilla and mandible: an assessment. 
  • Vascularized transplantation of skeletal muscle: a case report. 
  • Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas. 
  • Water, sodium, potassium, and D-xylose absorption in canine small bowel transplantation. 
  • What do we really know about allografts? 
  • Which criteria are used to clear patients to return to sport after primary ACL reconstruction? A scoping review. 
  • White matter changes in patients with breast cancer treated with high-dose chemotherapy and autologous bone marrow support. 
  • [Assessment of therapeutic results for simple bone cyst with percutaneous injection of autogenous bone marrow]. 
  • [Diagnosis and treatment of osteochondral lesions of the talus]. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Attarian, David Edward, Professor of Orthopaedic Surgery, Orthopaedics
  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Cohen, Seth Morris, Associate Professor of Head and Neck Surgery and Communication Sciences, Head and Neck Surgery & Communication Sciences
  • Starmer, Charles Franklin, Professor Emeritus of Computer Science, Computer Science
  • Toth, Cynthia Ann, Joseph A.C. Wadsworth Distinguished Professor of Ophthalmology, Biomedical Engineering